Guo Le, Zhou Linlin, Gao Qian, Zhang Aijun, Wei Jun, Hong Dantong, Chu Yuankui, Duan Xiangguo, Zhang Ying, Xu Guangxian
Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, General Hospital of Ningxia Medical University, Yinchuan, China.
Department of Medical Laboratory, School of Clinical Medicine, Ningxia Medical University, Yinchuan, China.
PLoS One. 2017 Jun 21;12(6):e0179772. doi: 10.1371/journal.pone.0179772. eCollection 2017.
MicroRNAs (miRNAs) are small noncoding nucleotides that play major roles in the response of host immune cells. Autophagy plays a key role in activating the antimicrobial host defense against Mycobacterium tuberculosis (M. tuberculosis). Whether miRNAs specifically influence the activation of macrophage autophagy during M. tuberculosis infection is largely unknown. In the present study, we demonstrate that Mycobacterium bovis Bacillus Calmette-Guérin (BCG) infection of macrophages leads to increased expression of miR-144-3p, which targets autophagy-related gene 4a (ATG4a), to inhibit autophagy activation and antimicrobial responses to BCG. Overexpression of miR-144-3p significantly decreased both mRNA and protein levels of ATG4a, inhibited the formation of autophagosomes in RAW264.7 cells and increased intracellular survival of BCG. However, transfection with miR-144-3p inhibitor led to an increase in ATG4a levels, accelerated the autophagic response in macrophages, and decreased BCG survival in macrophages. The experimental results of this study reveal a novel role of miR-144-3p in inhibiting autophagy activation by targeting ATG4a and enhancing BCG infection, and provide potential targets for developing improved treatment.
微小RNA(miRNA)是一类小的非编码核苷酸,在宿主免疫细胞的反应中发挥主要作用。自噬在激活宿主抗结核分枝杆菌(M. tuberculosis)的抗菌防御中起关键作用。miRNA是否在结核分枝杆菌感染期间特异性影响巨噬细胞自噬的激活在很大程度上尚不清楚。在本研究中,我们证明巨噬细胞感染牛分枝杆菌卡介苗(BCG)会导致miR-144-3p表达增加,其靶向自噬相关基因4a(ATG4a),以抑制自噬激活和对BCG的抗菌反应。miR-144-3p的过表达显著降低了ATG4a的mRNA和蛋白质水平,抑制了RAW264.7细胞中自噬体的形成,并增加了BCG的细胞内存活率。然而,用miR-144-3p抑制剂转染导致ATG4a水平升高,加速了巨噬细胞中的自噬反应,并降低了巨噬细胞中BCG的存活率。本研究的实验结果揭示了miR-144-3p通过靶向ATG4a抑制自噬激活并增强BCG感染的新作用,并为开发改进的治疗方法提供了潜在靶点。